Company Search
CEO Interview
Global Chinese Financial Forum
TSX_DNG on 2012-02-01 13:46Dynacor will be exhibiting at the Global Chinese Financial Forum on February 4th (Saturday) at the Vancouver Hilton Metrotown.
NAI Blog
The Multi-Billion Dollar Water Services Industry Keith Schaefer on 2012-02-17 09:21:04There is a multi-billion dollar water industry forming before investors’ eyes in the oil patch.
AMEX BIOTECHNOLOGY INDEX - BTK
NASDAQ BIOTECHNOLOGY (DRM)
DOW JONES US BIOTECHNOLOGY INDEX
Company News - Life Science
American Oriental Bioengineering Inc's board proposes reverse common stock split
Posted 2012-02-21 23:25NAI Editing
-Pharmaceutical company American Oriental Bioengineering Inc (NYSE:AOB) said on Tuesday that its board of directors plans to authorise a reverse stock split of the outstanding shares of its common stoTheratechnologies Announces a Supply, Distribution and Licensing Agreement With Actelion Pharmaceuticals Canada
Posted 2012-02-20 23:53NAI Editing
announced today that they have entered into a supply, distribution and licensing agreement with Actelion Pharmaceuticals Canada Inc.BioMarin Announces Chief Financial Officer Jeffrey Cooper to Leave the Company
Posted 2012-02-20 23:37NAI Editing
announced today that Jeffrey Cooper, Senior Vice President and Chief Financial Officer, plans to leave the company.Paladin Announces Strategic Partnership with Litha and Merging of South African Pharmaceutical Businesses
Posted 2012-02-20 23:34NAI Editing
today announced that it has entered into a strategic partnership whereby Paladin will accelerate its buy-out of the remaining 55.01% of Pharmaplan (Pty) Limited ("Pharmaplan") and merge the PharmaplanEuropean Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™
Posted 2012-02-16 23:43NAI Editing
announced today that Pixuvri™ (pixantrone dimaleate) has been granted a positive opinion for conditional approval from the European Medicines Agency's ("EMA") Committee for Medicinal Products for HumaNeoGenomics Reports 47% Revenue Growth and Profitability for Q4 2011; Provides Financial Outlook for 2012
Posted 2012-02-16 00:31NAI Editing
, a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full year 2011.BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
Posted 2012-02-16 00:14NAI Editing
announced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance of BDSI's patent application (No.Paladin Reports Sixteenth Consecutive Year of Record Revenues
Posted 2012-02-16 00:10NAI Editing
, a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and year ended December 31, 2011.Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
Posted 2012-02-15 00:02NAI Editing
-- Amgen (NASDAQ: AMGN) and Micromet, Inc.TPI Reports Second Quarter Fiscal Year 2012 Financial Results
Posted 2012-02-14 00:12NAI Editing
, a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced fi
Posted 2012-02-21 23:25
NAI Editing-Pharmaceutical company American Oriental Bioengineering Inc (NYSE:AOB) said on Tuesday that its board of directors plans to authorise a reverse stock split of the outstanding shares of its common stoTheratechnologies Announces a Supply, Distribution and Licensing Agreement With Actelion Pharmaceuticals Canada
Posted 2012-02-20 23:53
NAI Editingannounced today that they have entered into a supply, distribution and licensing agreement with Actelion Pharmaceuticals Canada Inc.BioMarin Announces Chief Financial Officer Jeffrey Cooper to Leave the Company
Posted 2012-02-20 23:37
NAI Editingannounced today that Jeffrey Cooper, Senior Vice President and Chief Financial Officer, plans to leave the company.Paladin Announces Strategic Partnership with Litha and Merging of South African Pharmaceutical Businesses
Posted 2012-02-20 23:34
NAI Editingtoday announced that it has entered into a strategic partnership whereby Paladin will accelerate its buy-out of the remaining 55.01% of Pharmaplan (Pty) Limited ("Pharmaplan") and merge the PharmaplanEuropean Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion For Conditional Approval On Marketing Authorization Application For Pixuvri™
Posted 2012-02-16 23:43
NAI Editingannounced today that Pixuvri™ (pixantrone dimaleate) has been granted a positive opinion for conditional approval from the European Medicines Agency's ("EMA") Committee for Medicinal Products for HumaNeoGenomics Reports 47% Revenue Growth and Profitability for Q4 2011; Provides Financial Outlook for 2012
Posted 2012-02-16 00:31
NAI Editing, a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full year 2011.BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
Posted 2012-02-16 00:14
NAI Editingannounced the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance of BDSI's patent application (No.Paladin Reports Sixteenth Consecutive Year of Record Revenues
Posted 2012-02-16 00:10
NAI Editing, a leading Canadian specialty pharmaceutical company, today reported its financial results for the fourth quarter and year ended December 31, 2011.Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgen's Acquisition of Micromet
Posted 2012-02-15 00:02
NAI Editing-- Amgen (NASDAQ: AMGN) and Micromet, Inc.TPI Reports Second Quarter Fiscal Year 2012 Financial Results
Posted 2012-02-14 00:12
NAI Editing, a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced fi